Research Article
Breast cancer risk is not increased in individuals with TWIST1 mutation confirmed Saethre–Chotzen syndrome: An Australian multicenter study
Article first published online: 16 APR 2009
DOI: 10.1002/gcc.20661
Copyright © 2009 Wiley-Liss, Inc.
Additional Information
How to Cite
James, P. A., Culling, B., Mullan, G., Jenkins, M., Elakis, G., Turner, A. M., Mowat, D. M., Wilson, M., Anderson, P., Savarirayan, R., Cliffe, S. T., Caramins, M., Buckley, M. F., Tucker, K. and Roscioli, T. (2009), Breast cancer risk is not increased in individuals with TWIST1 mutation confirmed Saethre–Chotzen syndrome: An Australian multicenter study. Genes, Chromosomes and Cancer, 48: 533–538. doi: 10.1002/gcc.20661
Publication History
- Issue published online: 6 MAY 2009
- Article first published online: 16 APR 2009
- Manuscript Accepted: 25 FEB 2009
- Manuscript Received: 9 DEC 2008
- Abstract
- Article
- References
- Cited By
Abstract
Saethre-Chotzen syndrome (SCS) is a rare autosomal dominant syndrome involving craniosynostosis, craniofacial abnormalities, and syndactyly. A recent Scandinavian study reported an increased risk of breast cancer in individuals with a clinical diagnosis of SCS. Because of the potential importance of this finding, we organized a multicenter study enrolling people with TWIST1 mutation confirmed SCS to determine if an increased risk of cancer is present. This study did not identify any cases of breast or ovarian cancer in a cohort of equivalent power to that reported previously. These results provide clinical reassurance that at present there is no evidence for breast cancer screening above standard practice for individuals with SCS. © 2009 Wiley-Liss, Inc.

1098-2264/asset/olbannercenter.jpg?v=1&s=171ee740767c9043cf5fcac8ef2214d9bb83ee9c)
